Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.
作者:
主题词
酰苯胺类(Anilides);动物(Animals);细胞凋亡(Apoptosis);抗药性, 肿瘤(Drug Resistance, Neoplasm);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);肝细胞生长因子(Hepatocyte Growth Factor);人类(Humans);咪唑类(Imidazoles);吲唑类(Indazoles);小鼠(Mice);肿瘤侵润(Neoplasm Invasiveness);神经母细胞瘤(Neuroblastoma);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-met(Proto-Oncogene Proteins c-met);吡啶类(Pyridines);血管内皮生长因子A(Vascular Endothelial Growth Factor A);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.3892/ijo.2016.3792
PMID
27922668
发布时间
2018-12-02
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文